AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Bottom 15%
#4474 out of 5210 analysts
Average Return
-2.14%
Win Rate
33%6 out of 18
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-12 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-08 - 2025-01-08 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-11 - 2024-01-11 | Strong Buy |
Nevro CorpNVRO | +11.80% | $4.83 | $4.26 | 2024-08-06 - 2024-12-03 | Strong Sell |
Irhythm Holdings IncIRTC | +9.67% | $108.72 | $119.23 | 2023-02-06 - 2024-02-06 | Strong Buy |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | 10 | Strong Buy | $34.00 | +34.12% | Maintains | 9 days ago |
Lemaitre Vascular IncLMAT | 3 | Hold | $94.00 | -11.45% | Maintains | 9 days ago |
Irhythm Holdings IncIRTC | 7 | Strong Buy | $200.00 | +57.54% | Maintains | 15 days ago |
Integer Holdings CorpITGR | 5 | Hold | $84.00 | -1.44% | Maintains | 15 days ago |
Resmed IncRMD | 2 | Hold | $270.00 | +5.75% | Maintains | a month ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.